Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
4
×
national blog main
national top stories
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
abbvie
acc
acorda therapeutics
acquisition
activist investor
aducanumab
alnylam pharmaceuticals
alzheimer's failure
ambys medicines
american college of cardiology
amicus therapeutics
ampio pharmaceuticals
What
drug
4
×
help
4
×
approved
bio
disease
fda
news
patients
roundup
acorda
adu
alzheimer's
aren’t
bad
beats
bids
biogen
brain
cancer
case
complicated
cope
depression
developers
dire
doses
drugs
episodes
failed
fight
fortune
friday
gene
gets
goes
good
group
heart
imminent
late
Language
Current search:
help
×
drug
×
" life sciences "
×
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More